|
USP7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.72259999995117E-07 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.6251444634463E-12 |
| Stage1-vs-Stage2 |
8.074200E-02 |
| Stage1-vs-Stage3 |
2.456000E-02 |
| Stage1-vs-Stage4 |
3.650200E-02 |
| Stage2-vs-Stage3 |
3.236600E-03 |
| Stage2-vs-Stage4 |
2.296700E-03 |
| Stage3-vs-Stage4 |
7.685000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.95889999998755E-07 |
| Normal-vs-Asian |
3.75899311677586E-12 |
| Caucasian-vs-AfricanAmerican |
6.957600E-01 |
| Caucasian-vs-Asian |
6.800600E-01 |
| AfricanAmerican-vs-Asian |
8.979200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.99440505513849E-15 |
| Normal-vs-Female |
1.6242562850266E-12 |
| Male-vs-Female |
5.386400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(41-60Yrs) |
1.4432899320127E-15 |
| Normal-vs-Age(61-80Yrs) |
1.63147273468667E-12 |
| Normal-vs-Age(81-100Yrs) |
3.836700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.161600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.147800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.348800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.398200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.894000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.913800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.99601999999466E-05 |
| Classical-VS-Follicular |
3.359200E-01 |
| Classical-VS-Other |
2.637200E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.75748999999836E-05 |
| Tall-VS-Other |
3.833600E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.858180E-01 |
| Follicular-VS-Normal |
5.86179993433689E-10 |
| Other-VS-Normal |
4.06790000000434E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.27675647831893E-14 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.880690E-03 |
|
|
